AKT serine/threonine protein kinase modulates baicalintriggered autophagy in human bladder cancer T24 cells

International Journal of Oncology

Volumn 42, Issue 3, 2013, Pages 993-1000

  Lin, Chingju ^a   Tsai, Shih Chang ^a   Tseng, Michael T ^e   Peng, Shu Fen ^a   Kuo, Sheng Chu ^a,b   Lin, Meng Wei ^c   Hsu, Yuan Man ^a   Lee, Miau Rong ^a   Amagaya, Sakae ^f   Huang, Wen Wen ^a   Wu, Tian Shung ^a,d   Yang, Jai Sing ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CARDINAL TIEN COLLEGE OF HEALTHCARE AND MANAGEMENT   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e University of Louisville School of Medicine   (United States)

^f NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

AKT; Autophagy; Baicalin; T24 cells; Traditional Chinese medicine

Indexed keywords

ACRIDINE ORANGE; BAICALIN; BECLIN 1; DANSYLCADAVERINE; MICROTUBULE ASSOCIATED PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; TRYPAN BLUE;

ARTICLE; AUTOPHAGY; BLADDER CANCER; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIGHT CHAIN; NICK END LABELING; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ACRIDINE ORANGE; ADENINE; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CADAVERINE; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; MEDICINE, CHINESE TRADITIONAL; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSGLUTAMINASES; UBIQUITIN-ACTIVATING ENZYMES; URINARY BLADDER NEOPLASMS;

EID: 84873683736     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1791     Document Type: Article

References (76)

1. Golstein P and Kroemer G: Cell death by necrosis: towards a molecular definition. Trends Biochem Sci 32: 37-43, 2007. (Pubitemid 46043552)
2. Bustamante-Marin X, Quiroga C, Lavandero S, Reyes JG and Moreno RD: Apoptosis, necrosis and autophagy are influenced by metabolic energy sources in cultured rat spermatocytes. Apoptosis 17: 539-550, 2012.
3. Edinger AL and Thompson CB: Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16: 663-669, 2004. (Pubitemid 39463117)
4. Mah LY and Ryan KM: Autophagy and cancer. Cold Spring Harb Perspect Biol 4: a008821, 2012.
5. Lockshin RA and Zakeri Z: Cell death in health and disease. J Cell Mol Med 11: 1214-1224, 2007.
6. Glick D, Barth S and Macleod KF: Autophagy: cellular and molecular mechanisms. J Pathol 221: 3-12, 2010.
7. Kaminskyy V and Zhivotovsky B: Proteases in autophagy. Biochim Biophys Acta 1824: 44-50, 2012.
8. Chen Y and Yu L: Autophagic lysosome reformation. Exp Cell Res 19: 142-146, 2013.
9. Mizushima N: The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol 22: 132-139, 2010.
10. Reggiori F: 1. Membrane origin for autophagy. Curr Top Dev Biol 74: 1-30, 2006.
11. Tanida I, Ueno T and Kominami E: LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 36: 2503-2518, 2004. (Pubitemid 39119762)
12. Yang WL, Perillo W, Liou D, Marambaud P and Wang P: AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells. J Surg Oncol 106: 680-688, 2012.
13. Ge W, Guo R and Ren J: AMP-dependent kinase and autophagic flux are involved in aldehyde dehydrogenase-2-induced protection against cardiac toxicity of ethanol. Free Radic Biol Med 51: 1736-1748, 2011.
14. Wu Y, Li X, Zhu JX, et al: Resveratrol-activated AMPK/SIRT1/ autophagy in cellular models of Parkinson's disease. Neurosignals 19: 163-174, 2011.
15. Li ZY, Yang Y, Ming M and Liu B: Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem Biophys Res Commun 414: 5-8, 2011.
16. Dagda RK, Zhu J, Kulich SM and Chu CT: Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease. Autophagy 4: 770-782, 2008.
17. Nishiyama Y, Shimada Y, Yokoi T, et al: Akt inactivation induces endoplasmic reticulum stress-independent autophagy in fibroblasts from patients with Pompe disease. Mol Genet Metab 107: 490-495-2012.
18. Tsai SC, Yang JS, Peng SF, et al: Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells. Int J Oncol 41: 1431-1442 2012.
19. Chen J, Crawford R and Xiao Y: Vertical inhibition of the PI3K/ Akt/mTOR pathway for the treatment of osteoarthritis. J Cell Biochem: Aug 28, 2012 (Epub ahead of print). doi: 10.1002/ jcb.24362.
20. Zeng T, Zhang CL, Song FY, et al: PI3K/Akt pathway activation was involved in acute ethanol-induced fatty liver in mice. Toxicology 296: 56-66, 2012.
21. Martelli AM, Evangelisti C, Follo MY, et al: Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells. Curr Med Chem 18: 2715-2726, 2011.
22. Hugel HM, Jackson N, May BH and Xue CC: Chinese herbs for dementia diseases. Mini Rev Med Chem 12: 371-379, 2012.
23. Chen S, Wu T, Kong X and Yuan H: Chinese medicinal herbs for measles. Cochrane Database Syst Rev: Nov 9, 2011, CD005531. doi: 10.1002/14651858. CD005531.pub4.
24. Yuan Y, Shuai L, Chen S, Huang L, Qin S and Yang Z: Flavonoids and antioxidative enzymes in temperature-challenged roots of Scutellaria baicalensis Georgi. Z Naturforsch C 67: 77-85, 2012.
25. Ma AT, Zhong XH, Liu ZM, et al: Protective effects of baicalin against bromocriptine induced abortion in mice. Am J Chin Med 37: 85-95, 2009.
26. Waisundara VY, Siu SY, Hsu A, Huang D and Tan BK: Baicalin upregulates the genetic expression of antioxidant enzymes in Type-2 diabetic Goto-Kakizaki rats. Life Sci 88: 1016-1025, 2011.
27. Bing-Rong Z, Song-Liang J, Xiao EC, et al: Protective effect of the Baicalin against DNA damage induced by ultraviolet B irradiation to mouse epidermis. Photodermatol Photoimmunol Photomed 24: 175-182, 2008.
28. Li HY, Hu J, Zhao S, et al: Comparative study of the effect of baicalin and its natural analogs on neurons with oxygen and glucose deprivation involving innate immune reaction of TLR2/ TNFalpha. J Biomed Biotechnol: Mar 21, 2012 (Epub). 267890, doi: 10.1155/2012/267890.
29. Cao Y, Mao X, Sun C, et al: Baicalin attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-oxidative and anti-apoptotic pathways. Brain Res Bull 85: 396-402, 2011.
30. de Carvalho RS, Duarte FS and de Lima TC: Involvement of GABAergic non-benzodiazepine sites in the anxiolytic-like and sedative effects of the flavonoid baicalein in mice. Behav Brain Res 221: 75-82, 2011.
31. Zhu J, Wang J, Sheng Y, et al: Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis. PLoS One 7: e35523, 2012.
32. Fu S, Sun C, Tao X and Ren Y: Anti-inflammatory effects of active constituents extracted from Chinese medicinal herbs against Propionibacterium acnes. Nat Prod Res 26: 1746-1749, 2012.
33. Chu ZY, Chu M and Teng Y: Effect of baicalin on in vivo anti-virus. Zhongguo Zhong Yao Za Zhi 32: 2413-2415, 2007 (In Chinese).
34. Kitamura K, Honda M, Yoshizaki H, et al: Baicalin, an inhibitor of HIV-1 production in vitro. Antiviral Res 37: 131-140, 1998. (Pubitemid 28186303)
35. Qiao H, Han H, Hong D, Ren Z, Chen Y and Zhou C: Protective effects of baicalin on carbon tetrachloride induced liver injury by activating PPARgamma and inhibiting TGFbeta1. Pharm Biol 49: 38-45, 2011.
36. Hwang JM, Wang CJ, Chou FP, et al: Protective effect of baicalin on tert-butyl hydroperoxide-induced rat hepatotoxicity. Arch Toxicol 79: 102-109, 2005.
37. Chiu YW, Lin TH, Huang WS, et al: Baicalein inhibits the migration and invasive properties of human hepatoma cells. Toxicol Appl Pharmacol 255: 316-326, 2011.
38. Shieh DE, Cheng HY, Yen MH, Chiang LC and Lin CC: Baicalin-induced apoptosis is mediated by Bcl-2-dependent, but not p53-dependent, pathway in human leukemia cell lines. Am J Chin Med 34: 245-261, 2006.
39. Motoo Y and Sawabu N: Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines. Cancer Lett 86: 91-95, 1994. (Pubitemid 24318987)
40. Huang Y, Hu J, Zheng J, et al: Down-regulation of the PI3K/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin. J Exp Clin Cancer Res 31: 48, 2012.
41. Chen WC, Kuo TH, Tzeng YS and Tsai YC: Baicalin induces apoptosis in SW620 human colorectal carcinoma cells in vitro and suppresses tumor growth in vivo. Molecules 17: 3844-3857, 2012.
42. Lee DH, Kim C, Zhang L and Lee YJ: Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells. Biochem Pharmacol 75: 2020-2033, 2008.
43. Zheng J, Hu JD, Chen YY, et al: Baicalin induces apoptosis in leukemia HL-60/ADR cells via possible down-regulation of the PI3K/Akt signaling pathway. Asian Pac J Cancer Prev 13: 1119-1124, 2012.
44. Lu HF, Hsueh SC, Ho YT, et al: ROS mediates baicalin-induced apoptosis in human promyelocytic leukemia HL-60 cells through the expression of the Gadd153 and mitochondrial-dependent pathway. Anticancer Res 27: 117-125, 2007.
45. Zhang X, Tang X, Liu H, Li L, Hou Q and Gao J: Autophagy induced by baicalin involves downregulation of CD147 in SMMC-7721 cells in vitro. Oncol Rep 27: 1128-1134, 2012.
46. Huang WW, Yang JS, Pai SJ, et al: Bufalin induces G(0)/G(1) phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells. Mutat Res 732: 26-33, 2012.
47. Kim JY, Cho TJ, Woo BH, et al: Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells. Arch Oral Biol 57: 1018-1025, 2012.
48. Munafo DB and Colombo MI: A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. J Cell Sci 114: 3619-3629, 2001. (Pubitemid 33041044)
49. McCoy F, Hurwitz J, McTavish N, et al: Obatoclax induces Atg7- dependent autophagy independent of beclin-1 and BAX/BAK. Cell Death Dis 1: e108, 2010.
50. Barth S, Glick D and Macleod KF: Autophagy: assays and artifacts. J Pathol 221: 117-124, 2010.
51. Mizushima N and Yoshimori T: How to interpret LC3 immunoblotting. Autophagy 3: 542-545, 2007. (Pubitemid 350060049)
52. Yu K, Gong Y, Lin Z and Cheng Y: Quantitative analysis and chromatographic fingerprinting for the quality evaluation of Scutellaria baicalensis Georgi using capillary electrophoresis. J Pharm Biomed Anal 43: 540-548, 2007. (Pubitemid 44960586)
53. Zhou XQ, Liang H, Lu XH, Cai SQ, Wang B and Zhao YY: Flavonoids from Scutellaria baicalensis and their bioactivities. Beijing Da Xue Xue Bao 41: 578-584, 2009 (In Chinese).
54. Liu B, Shi RB and Zhu LJ: HPLC fingerprint of flavonoids of Kushen Tang and its correlation to Scutellaria baicalensis and Sophora flavescens. Zhongguo Zhong Yao Za Zhi 32: 1631-1634, 2007 (In Chinese).
55. Kim YH, Jeong DW, Kim YC, Sohn DH, Park ES and Lee HS: Pharmacokinetics of baicalein, baicalin and wogonin after oral administration of a standardized extract of Scutellaria baicalensis, PF-2405 in rats. Arch Pharm Res 30: 260-265, 2007.
56. Hirunuma M, Shoyama Y, Sasaki K, et al: Flavone-catalyzed apoptosis in Scutellaria baicalensis. Phytochemistry 72: 752-760, 2011.
57. Choi J, Conrad CC, Malakowsky CA, Talent JM, Yuan CS and Gracy RW: Flavones from Scutellaria baicalensis Georgi attenuate apoptosis and protein oxidation in neuronal cell lines. Biochim Biophys Acta 1571: 201-210, 2002. (Pubitemid 34686922)
58. Pan TL, Wang PW, Leu YL, Wu TH and Wu TS: Inhibitory effects of Scutellaria baicalensis extract on hepatic stellate cells through inducing G2/M cell cycle arrest and activating ERK-dependent apoptosis via Bax and caspase pathway. J Ethnopharmacol 139: 829-837, 2012.
59. Li HB, Jiang Y and Chen F: Separation methods used for Scutellaria baicalensis active components. J Chromatogr B Analyt Technol Biomed Life Sci 812: 277-290, 2004. (Pubitemid 39535417)
60. Wang S, Zheng Z, Weng Y, et al: Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sci 74: 2467-2478, 2004. (Pubitemid 38324603)
61. Zhu H, Wang Z, Xing Y, et al: Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. J Ethnopharmacol 141: 714-720, 2012.
62. Hu Q, Noor M, Wong YF, et al: In vitro anti-fibrotic activities of herbal compounds and herbs. Nephrol Dial Transplant 24: 3033-3041, 2009.
63. Yang BL, Chen HJ, Chen YG, et al: Inhibitory effects of baicalin on orthotopic xenografts of colorectal cancer cells that are deficient in a mismatch repair gene in nude mice. Int J Colorectal Dis: Aug 23, 2012 (Epub ahead of print).
64. Ren X, Li CL, Wang HX, et al: Molecular mechanism of HL-60 cell apoptosis induced by baicalin. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20: 847-851, 2012 (In Chinese).
65. Carew JS, Kelly KR and Nawrocki ST: Autophagy as a target for cancer therapy: new developments. Cancer Manag Res 4: 357-365, 2012.
66. Goussetis DJ, Altman JK, Glaser H, McNeer JL, Tallman MS and Platanias LC: Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide. J Biol Chem 285: 29989-29997, 2010.
67. Wang N, Feng Y, Zhu M, et al: Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem 111: 1426-1436, 2010.
68. Filomeni G, Desideri E, Cardaci S, et al: Carcinoma cells activate AMP-activated protein kinase-dependent autophagy as survival response to kaempferol-mediated energetic impairment. Autophagy 6: 202-216, 2010.
69. Shahjee HM, Koch KR, Guo L, Zhang CO and Keay SK: Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells. J Exp Clin Cancer Res 29: 160, 2010.
70. Chen M, Cassidy A, Gu J, et al: Genetic variations in PI3K-AKTmTOR pathway and bladder cancer risk. Carcinogenesis 30: 2047-2052, 2009.
71. Champelovier P, El Atifi M, Mantel F, et al: In vitro tumoral progression of human bladder carcinoma: role for TGFbeta. Eur Urol 48: 846-851, 2005. (Pubitemid 41495393)
72. Stueckle TA, Lu Y, Davis ME, et al: Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol 261: 204-216, 2012.
73. Askham JM, Platt F, Chambers PA, Snowden H, Taylor CF and Knowles MA: AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K. Oncogene 29: 150-155, 2010.
74. Dickstein RJ, Nitti G, Dinney CP, Davies BR, Kamat AM and McConkey DJ: Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells. Cancer Biol Ther 13: 1325-1338, 2012.
75. Wu D, Tao J, Xu B, et al: Phosphatidylinositol 3-kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells. Urol Int 86: 346-354, 2011.
76. Zheng J, Hu JD, Huang Y and Chen BY: Effects of baicalin on proliferation and apoptosis of adriamycin-resistant human leukemia HL-60/ADR cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17: 1198-1202, 2009 (In Chinese).